Transcription Factor Matrix for Stem Cell Differentiation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for differentiating pluripotent stem cells into specific cell types face challenges due to the complexity of transcription factor networks, with many possible combinations and low efficiency, and the difficulty in predicting the direction of cell differentiation accurately, especially between humans and mice.

Innovation Solution

A human gene expression correlation matrix is created to select specific transcription factor cocktails, such as those including NEUROG1, NEUROG2, NEUROG3, NEUROD1, and NEUROD2, to accurately differentiate human pluripotent stem cells into desired cell types like neural, hepatoblast, and hematopoietic cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If transcription factor combinations are used to differentiate pluripotent stem cells, then cell differentiation can be achieved, but the complexity of selecting the right combination and predicting differentiation direction increases significantly

Engineering Contradiction:
Improvedifferentiation efficiencyVSAvoidtranscription factor combination complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent uses gene expression correlation matrices derived from mouse data as a template or copy to guide human stem cell differentiation. By copying the successful transcription factor combination strategies from mouse models and adapting them to human cells, the patent reduces the complexity of de novo optimization while maintaining high differentiation efficiency

Inventive Principle:
Principle #26Copying

Solution Approach 2:

The patent performs preliminary analysis by creating gene expression correlation matrices and identifying key transcription factor combinations before actual differentiation experiments. This preliminary characterization of transcription factor networks allows researchers to predict differentiation directions and select optimal factor combinations in advance, reducing trial-and-error complexity

Inventive Principle:
Principle #10Preliminary action

2Measurement precision

If gene expression correlation matrix is used to predict differentiation direction, then prediction accuracy improves, but the time and resources required for matrix creation and analysis increase

Engineering Contradiction:
Improvedifferentiation direction prediction accuracyVSAvoidmatrix creation and analysis time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent creates gene expression correlation matrices from publicly available transcriptome data rather than generating new experimental data. By copying and reanalyzing existing genomic datasets, the patent achieves high prediction accuracy without the time-consuming process of conducting new high-throughput experiments

Inventive Principle:
Principle #26Copying

Solution Approach 2:

The gene expression correlation matrix serves multiple functions: it predicts differentiation directions, identifies key transcription factors, and guides experimental design. This multi-functionality reduces the need for separate analytical approaches, saving time while maintaining comprehensive prediction accuracy

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS20240124836A1Method For Differentiating Pluripotent Stem Cells Into Desired Cell Type
Publication Date: 2024.04.18 KEIO UNIV
  • US20240124836A1 patent drawing
  • US20240124836A1 patent drawing
  • US20240124836A1 patent drawing

AI summary

Provided is a method of differentiating a pluripotent stem cell of mammalian origin into a desired cell type by predicting the direction of cell differentiation to be caused by induction of expression of a transcription factor. A human gene expression correlation matrix using human cells has been newly created, and further, it has been confirmed that human pluripotent stem cells can be differentiated into a desired cell type by introducing, into the human pluripotent stem cells, a transcription factor cocktail selected from the matrix.